IL1B and breast neoplasm: The fact that aggressive IRISOE TNBC cells produce and secrete high-level IL-1β in HIF-1α and NF-κB-dependent manner [61] is consistent with recent reports showing IL-1β is a critical mediator of inflammation leading to tumor progression within breast tumor microenvironment [62, 63].